Listen to this article
Last week, Holly and I had the opportunity to attend the inaugural NET Masterclass organised by the NET Academy (UCL and the Royal Free Hospital) which was supported by Neuroendocrine Cancer UK. It was a dedicated education day bringing together healthcare professionals from across the world to share learning, best practice and to deepen understanding of neuroendocrine cancer.
The sessions covered a wide range of topics, including advances in diagnostics, tissue and imaging biomarkers and the role of dual PET scans (FDG and dotatate). There were also presentations about evolving treatment pathways, the role of surgery (including transplantation of the liver and small bowel), endoscopy, SSAs, SACTs, TKIs and PRRT. It was interesting to see the data relating to the efficacy of treatments depending on the person’s diagnosis and related metastases, functional status of the tumour and reported quality of life.
The second day had an afternoon stream for Nurses and Dieticians which was well attended. The lectures covered topics including the role of the OT in structured fatigue management, sitting with distress and causes and treatments for diarrhoea and carcinoid crisis.
What really stood out for us was the role of MDT discussion in patient centred decision making relating to treatment options and the sequence of those treatments. It was particularly valuable to hear from health care professionals delivering excellence in neuroendocrine cancer care with practical insights we can bring back to enhance our support services.
A key theme throughout the day was the importance of early recognition and timely referral, alongside the need for consistent, accessible information for patients and families. The discussions reinforced how vital collaborative, multidisciplinary working is in ensuring people with neuroendocrine cancers receive coordinated, high-quality care wherever they are in their journey.
For us as NCUK nurses, the Masterclass was a welcome opportunity to connect with` colleagues, refresh our knowledge, and reflect on how we can continue to strengthen the support we offer through the helpline, clinics, and wider patient services.
We’re looking forward to building on the learning and sharing relevant updates with the wider team over the coming weeks.
Erica, Neuroendocrine Cancer UK’s Health & Well-being Specialist Cancer Nurse.